Immune Therapeutics Story
| IMUNDelisted Stock | USD 0.06 0 4.76% |
About 62% of Immune Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Immune Therapeutics pink sheet suggests that many investors are alarmed at this time. Immune Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Immune Therapeutics. The current market sentiment, together with Immune Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Immune Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Immune Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immune daily returns and investor perception about the current price of Immune Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Immune |
Requested story not found. it has been either deleted or moved. View all stories for Immune Therapeutics.
Immune Therapeutics Latest Timeline
Immune Therapeutics is listed for 0.06. About 30.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 333.33. Immune Therapeutics had not issued any dividends in recent years. The entity had 1:1000 split on the 6th of May 2021.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Immune Pink Sheet
If you are still planning to invest in Immune Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immune Therapeutics' history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |